Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress

JACC: Cardiovascular Interventions

Volumn 2, Issue 3, 2009, Pages 253-262

  Pendyala, Lakshmana K ^a   Li, Jinsheng ^a   Shinke, Toshiro ^a   Geva, Sarah ^a   Yin, Xinhua ^a   Chen, Jack P ^a   King III, Spencer B ^a   Robinson, Keith A ^a   Chronos, Nicolas A F ^a   Hou, Dongming ^a  

^a Saint Joseph's Hospital of Atlanta   (United States)

Author keywords

endothelial function; inflammation; oxidative stress; paclitaxel eluting stent

Indexed keywords

GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM; PACLITAXEL; SUPEROXIDE; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; INFLAMMATION; INFLAMMATORY CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SWINE; VASODILATATION; VASOMOTOR DISORDER; ANIMAL; CHEMICALLY INDUCED; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE MODEL; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; INFLAMMATION; OXIDATIVE STRESS; PACLITAXEL; SWINE;

EID: 62149086297     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.11.009     Document Type: Article

References (30)

1. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
2. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
3. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
4. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
5. Dawkins K.D., Grube E., Guagliumi G., et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
6. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
7. Luscher T.F., Steffel J., Eberli F.R., et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115 (2007) 1051-1058
8. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
9. Ellis S.G., Colombo A., Grube E., et al. Incidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 years. J Am Coll Cardiol 49 (2007) 1043-1051
10. Weissman N.J., Ellis S.G., Grube E., et al. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J 28 (2007) 1574-1582
11. Togni M., Raber L., Cocchia R., et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 120 (2007) 212-220
12. Shin D.I., Kim P.J., Seung K.B., et al. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction. Int Heart J 48 (2007) 553-567
13. Lavi S., Yang E.H., Prasad A., et al. The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension 51 (2008) 127-133
14. Landmesser U., Hornig B., and Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 109 (2004) II27-II33
15. Shinke T., Li J., Chen J.P., et al. Incidence of intramural thrombus after overlapping paclitaxel-eluting stents: angioscopic and histopathologic analysis in porcine coronary arteries. Circulation Interv 1 (2008) 28-35
16. Shinke T., Geva S., Pendyala L., et al. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries. Int J Cardiol (2008) Aug 9 [E-pub ahead of print]
17. Ohwada T., Saito T., Saitoh S., et al. Specificity of vascular reactivity and remodeling after repeated endothelial injury in a swine model. Int Heart J 47 (2006) 297-310
18. Li J., Jabara R., Pendyala L., et al. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents. J Am Coll Cardiol Intv 1 (2008) 279-285
19. Mohazzab K.M., Kaminski P.M., and Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266 (1994) H2568-H2572
20. Meier P., Zbinden R., Togni M., et al. Coronary collateral function long after drug-eluting stent implantation. J Am Coll Cardiol 49 (2007) 15-20
21. Pendyala L., Jabara R., Shinke T., et al. Drug-eluting stents: present and future. Cardiovasc Hematol Agents Med Chem 6 (2008) 105-115
22. Hofma S.H., van der Giessen W.J., van Dalen B.M., et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 166-170
23. Gössl M., Rosol M., Malyar N.M., et al. Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries. Anat Rec Part A 272 (2003) 526-537
24. Axel D.I., Kunert W., Göggelmann C., et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96 (1997) 636-645
25. Farb A., Heller P.F., Shroff S., et al. Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104 (2001) 473-479
26. Kotur-Stevuljevic J., Memon L., Stefanovic A., et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 40 (2007) 181-187
27. Quyyumi A.A., Dakak N., Andrews N.P., et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 95 (1995) 1747-1755
28. Aslan M., Ryan T.M., Townes T.M., et al. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 278 (2003) 4194-4204
29. MacPherson J.C., Comhair S.A., Erzurum S.C., et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 166 (2001) 5763-5772
30. Brott B.C., Anayiotos A.S., Chapman G.D., Anderson P.G., and Hillegass W.B. Severe, diffuse coronary artery spasm after drug-eluting stent placement. J Invasive Cardiol 18 (2006) 584-592